abagovomab 35
abciximab 32
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 20
aducanumab 13
afasevikumab 20
alacizumab_pegol 15
alemtuzumab 25
alirocumab 25
amatuximab 41
andecaliximab 23
anifrolumab 22
anrukinzumab 22
aprutumab 22
aprutumab_ixadotin 22
arcitumomab 27
ascrinvacumab 7
atezolizumab 16
atinumab 17
avelumab 15
basiliximab 34
bavituximab 38
begelomab 31
benralizumab 26
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 13
bleselumab 19
blinatumomab 36
blosozumab 30
bococizumab 17
brazikumab 15
brentuximab_vedotin 32
briakinumab 18
brodalumab 13
brolucizumab 28
brontictuzumab 25
burosumab 17
cabiralizumab 25
camrelizumab 14
canakinumab 26
cantuzumab_ravtansin 46
carlumab 16
carotuximab 31
cergutuzumab_amunaleukin2 27
cergutuzumab_amunaleukin 27
certolizumab_pegol 25
cetiximab 47
citatuzumab_bogatox 27
cixutumumab 29
clivatuzumab_tetraxetan 22
codrituzumab 32
conatumumab 14
concizumab 33
crenezumab 22
crizanlizumab 25
crotedumab 22
dacetuzumab 22
daclizumab 16
dalotuzumab 39
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 11
demcizumab 26
denosumab 11
depatuxizumab 23
depatuxizumab_mafodotin 23
dezamizumab 18
dinutuximab 36
diridavumab 26
domagrozumab 17
drozitumab 20
duligotuzumab 21
durvalumab 12
dusigitumab 20
efalizumab 32
efungumab 32
eldelumab 15
elezanumab 20
elgemtumab 12
elotuzumab 18
emactuzumab 19
emapalumab 25
emibetuzumab 16
enavatuzumab 25
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 24
enoticumab 18
ensituximab 36
eptinezumab 19
erenumab 26
etaracizumab 18
etrolizumab 22
evinacumab 22
evolocumab 18
farletuzumab 15
fasinumab 22
fezakinumab 20
fibatuzumab 12
ficlatuzumab 23
firivumab 34
flanvotumab 18
fletikumab 24
foralumab 15
foravirumab 14
fremanezumab 30
fresolimumab 17
fulranumab 23
futuximab 32
galcanezumab 22
ganitumab 28
gantenerumab 11
gemetuzumab 28
gemtuzumab2 25
gemtuzumab 28
gevokizumab 24
girentuximab 36
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 27
ibalizumab 28
ibritumomab 35
icrucumab 10
idarucizumab 38
ifabotuzumab 12
imalumab 18
imgatuzumab 19
inclacumab 20
indatuximab_ravtansin 35
indusatumab 16
inebilizumab 30
intetumumab 16
iodine_girentuximab 30
ipilimumab 3
iratumumab 13
isatuximab 38
itolizumab 27
ixekizumab 34
labetuzumab_govitecan 27
lambrolizumab 27
lampalizumab 26
lanadelumab 18
landogrozumab 18
laprituximab 27
lebrikizumab 37
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 39
lirilumab 22
lodelcizumab 16
lokivetmab 26
lorvotuzumab_mertansin 29
lucatumumab 28
lumretuzumab 20
lupartumab 20
lutikizumab 21
margetuximab 36
milatuzumab 42
mirvetuximab 36
mirvetuximab_soravtansin 36
modotuximab 41
mogamulizumab 36
monalizumab 16
motavizumab 34
moxetumomab_pasudotox 33
namilumab 18
naratuximab 29
naratuximab_emtansin 29
narnatumab 19
navicixizumab2 31
navicixizumab 27
navivumab 36
necitumumab 12
nemolizumab 24
nesvacumab 17
nivolumab 14
obiltoxaximab 24
obinutuzumab 39
ocaratuzumab 26
ofatumumab 19
olaratumab 20
olokizumab 26
omalizumab 20
onartuzumab 22
ontuxizumab 29
opicinumab 14
orticumab 16
otelixizumab 39
oxelumab 13
ozanezumab 31
pamrevlumab 12
panobacumab 31
parsatuzumab 25
pasotuxizumab 23
pateclizumab 16
patritumab 20
pembrolizumab 27
perakizumab 23
pidilizumab 19
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 39
prezalumab 15
pritoxaximab 38
quilizumab 23
racotumomab 28
radretumab 15
ralpancizumab 21
ramucirumab 14
ranevetmab 30
ranibizumab 24
refanezumab 29
remtolumab 20
rilotumumab 20
rinucumab 18
risankizumab 35
rituximab 20
rivabazumab 20
robatumumab 20
roledumab 33
romosozumab 21
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 22
sacituzumab 30
sacituzumab_govitecan 30
samalizumab 25
sapelizumab 24
sarilumab 19
secukinumab 16
seribantumab 17
setoxaximab 44
sifalimumab 11
siltuximab 27
simtuzumab 27
sirukumab 15
solanezumab 27
solitomab 31
stamulumab 20
suptavumab 25
suvizumab 21
tabalumab 15
tadocizumab 18
tamtuvetmab 34
tanezumab 22
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 21
tesidolumab 22
tezepelumab 25
tigatuzumab 17
tildrakizumab 19
timolumab 15
tisotumab 15
tosatoxumab 42
tositumomab 35
tralokinumab 27
trastuzumab 23
tregalizumab 34
trevogrumab 13
ublituximab 31
urelumab 20
ustekinumab 28
utomilumab 29
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 16
vantictumab 22
vanucizumab2 24
vanucizumab 29
varlilumab 14
vatelizumab 21
vedolizumab 29
veltuzumab 15
vesencumab 13
vorsetuzumab 27
vorsetuzumab_mafodotin 27
vunakizumab 34
xentuzumab 20
zatuximab 41
